Biorestorative Therapies, Inc. BRTX
2.55
0.04
1.59%
as of 25 Sep
- Market cap
- $3.5M
- P/E
- 0.0×
Follow BRTX
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
| (241.50%) | (321.48%) | (208.21%) | (137.34%) |
+8 more TTM periods Free account |
|
| (147.75%) | (174.11%) | (125.35%) | (87.06%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(439.82%) | 6,268.49% | (801.27%) | (251.36%) | |
Average Days of Receivables |
13.56 | 15.73 | 12.76 | 9.05 | |
Free Cash Flow per Share |
(13.33) | (24.25) | (23.63) | (22.03) | |
Free Cash Flow |
(11.82) | (10.91) | (10.77) | (9.63) | |
Capital Expenditures |
— | (0.12) | (0.05) | (0.11) | |
Piotroski F-Score |
2.00 | 3.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(178.58%) | (325.99%) | (160.10%) | (77.87%) | |
Accounts Receivable Turnover |
18.69 | 3.53 | 4.30 | 28.55 | |
Accounts Payable Turnover |
0.04 | 0.03 | 0.04 | 0.08 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
8,601.36 | 20,573.42 | 12,308.37 | 6,725.48 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2,619.20% | 2,806.42% | 2,662.75% | 1,498.28% | |
Selling, General and Administrative Expense of Revenue |
1,447.56% | 1,637.00% | 1,215.68% | 759.15% | |
Share Based Compensation of Revenue |
448.92% | 924.55% | 796.43% | 485.41% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.07 | 0.76 | 0.85 | 0.89 | |
Depreciation/Fixed assets |
0.64 | 0.59 | 0.67 | 0.60 | |
Capex/Depreciation |
0.00 | (0.55) | (0.24) | (0.53) | |
Revenue per Share |
0.40 | 0.80 | 0.84 | 1.38 | |
Operating CF per Share |
(13.33) | (23.99) | (23.52) | (21.79) | |
Capex per Share |
0.00 | (0.26) | (0.11) | (0.25) | |
Capex to Sales |
0.00 | 0.32 | 0.13 | 0.18 | |
Net Profit Margin |
(3,089.30%) | (3,959.41%) | (3,304.77%) | (1,771.91%) |
Columns are period end dates